Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07490197 · ClinicalTrials.gov registry record
Acute Subdural Hematoma
A clinical trial, sponsored by Methodist Health System.
- Recruiting
- Registry status
- 100
- Enrollment target
NCT07490197: Recruiting study, sponsored by Methodist Health System.
NCT07490197 is a clinical trial that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07490197 is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.
Primary Outcome
This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center trauma bay with Acute subdural hematoma . Enrollment will terminate once adequate number of interventions have been observed for clinical significance to be established. We anticipate 5 years of data to be captured (January 2018 through December 2023).
Interventions
- OTHER Medical/Phenotype Data Collection Procedures & Data to be Collected
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-02 |
| Est. Completion | 2028-02 |
What NCT07490197 shows while recruiting
NCT07490197 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Medical/Phenotype Data Collection Procedures & Data to be Collected is the first listed.
NCT07490197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07490197 about?
NCT07490197 is a clinical study titled "Acute Subdural Hematoma". This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.
What is the current status of trial NCT07490197?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2026-02. Estimated completion is 2028-02.
What interventions are being tested in trial NCT07490197?
The interventions under investigation include: Medical/Phenotype Data Collection Procedures & Data to be Collected (OTHER).
Who is sponsoring clinical trial NCT07490197?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia